Monoclonal Anti-TAZ antibody produced in mouse
SIGMA/WH0006901M12 - clone 1B10, purified immunoglobulin, buffered aqueous solution
Synonym: Anti-BTHS; Anti-CMD3A; Anti-EFE; Anti-EFE2; Anti-G4.5; Anti-LVNCX; Anti-XAP2; Anti-tafazzin (cardiomyopathy, dilated 3A (X-linked); endocardial fibroelastosis 2; Barth syndrome)
MDL Number: MFCD03792065
Product Type: Chemical
Western Blotting TAZ monoclonal antibody, clone 1B10. Western Blot analysis of TAZ expression in PC-12.
Western Blotting TAZ monoclonal antibody, clone 1B10 Western Blot analysis of TAZ expression in SW-13.
Western Blotting TAZ monoclonal antibody, clone 1B10. Western Blot analysis of TAZ expression in human kidney.
Western Blotting TAZ monoclonal antibody, clone 1B10. Western Blot analysis of TAZ expression in human uterus myoma.
Western Blotting QC Western Blot detection against Immunogen (54.56 kDa).
ELISA Detection limit for recombinant GST tagged TAZ is approximately 3 ng/mL as a capture antibody.
| antibody form | purified immunoglobulin |
| antibody product type | primary antibodies |
| biological source | mouse |
| clone | 1B10, monoclonal |
| conjugate | unconjugated |
| form | buffered aqueous solution |
| GenBank accession no. | BC011515   |
| isotype | IgG2aκ |
| Quality Level | 100 |
| shipped in | dry ice |
| species reactivity | human, rat, mouse |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | indirect ELISA: suitable |
| western blot: 1-5 μg/mL | |
| UniProt accession no. | Q16635 |
| Disclaimer: | Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals. |
| General description: | This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. (provided by RefSeq) |
| Immunogen: | TAZ (AAH11515, 1 a.a. ~ 262 a.a) full-length recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. Sequence MPLHVKWPFPAVPPLTWTLASSVVM |
| Legal Information: | GenBank is a registered trademark of United States Department of Health and Human Services |
| Physical form: | Solution in phosphate buffered saline, pH 7.4 |
| RIDADR | NONH for all modes of transport |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |